4.7 Article

Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

Facing the New Covid-19 Reality

Wafaa M. M. El-Sadr et al.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Medicine, General & Internal

The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study

Ahmet Naci Emecen et al.

Summary: This study describes the presence of symptoms in COVID-19 patients within 6 months after diagnosis and identifies associated risk factors for reporting symptoms. It provides guidance for healthcare providers in allocating resources for post-COVID rehabilitation.

IRISH JOURNAL OF MEDICAL SCIENCE (2023)

Article Health Care Sciences & Services

Health-Related Quality of Life Mildly Affected Following COVID-19: a Retrospective Pre-post Cohort Study with a Propensity Score-Matched Control Group

Brittany Lapin et al.

Summary: COVID-19 has a significant impact on the health-related quality of life (HRQOL) of patients, with reductions in global mental and physical health observed. One quarter of COVID-19 patients experienced meaningful reductions in HRQOL, and the decline in HRQOL was significantly worse than the control group. Predictors of worsening HRQOL included being female, having depression, being hospitalized for COVID-19, and better pre-infection global health.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Review Multidisciplinary Sciences

Quality of life of COVID 19 patients after discharge: Systematic review

H. M. R. K. G. Nandasena et al.

Summary: This systematic review examined the quality of life (QOL) and associated factors in COVID-19 patients following discharge or recovery. The results showed that regardless of the time elapsed, the QOL of post COVID-19 patients was significantly impacted. Female sex, older age, co-morbidities, Intensive Care Unit (ICU) admission, prolonged ICU stay, and being mechanically ventilated were the most frequently reported factors associated with low QOL.

PLOS ONE (2022)

Article Medicine, General & Internal

Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study

Cesar Fernandez-de-las-Penas et al.

Summary: This study investigated the differences in COVID-19 related symptoms and post-COVID symptoms between male and female COVID-19 survivors. It found that post-COVID symptoms were present in up to 60% of hospitalized COVID-19 survivors eight months after the infection, with female survivors experiencing more symptoms than males. Female sex was also associated with a higher risk of developing mood disorders and other long-term post-COVID symptoms.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Infectious Diseases

Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City

Rosa Maria Wong-Chew et al.

Summary: This study reports on the prevalence and associated risk factors of long-term health consequences of COVID-19 in patients discharged from a temporary COVID-19 hospital in Mexico City. Neurological, dermatological, and mood disorder symptoms were found to persist in over 30% of patients at 90 days post-discharge. While most symptoms decreased in frequency between day 30 and 90, alopecia and the dermatological symptom cluster significantly increased. Women were more prone to develop long-term symptoms, and invasive mechanical ventilation also increased the frequency of symptoms at 30 days post-discharge.

THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2022)

Editorial Material Neurosciences

Cognitive sequelae of COVID-19,a post-pandemic threat. Should we be worried about the brain fog?

Oscar H. Del Brutto

ARQUIVOS DE NEURO-PSIQUIATRIA (2022)

Review Dermatology

Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management

Manabu Ohyama et al.

Summary: COVID-19 recovery may lead to hair loss, which can have a significant impact on patients' mental and social well-being. The underlying mechanisms of hair loss after SARS-CoV-2 infection are still not fully understood. Treatment options include managing COVID-19 symptoms and improving hair loss associated with the telogen effluvium phase. Topical minoxidil has been suggested as a potential treatment, but more clinical research is needed to confirm its effectiveness.

JOURNAL OF DERMATOLOGY (2022)

Article Multidisciplinary Sciences

Persistent COVID-19 symptoms in a community study of 606,434 people in England

Matthew Whitaker et al.

Summary: This study characterizes Long COVID using data from the REACT-2 community-based study in England, estimating the prevalence of persistent symptoms and identifying risk factors. It also finds evidence of symptom clustering.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Long COVID occurrence in COVID-19 survivors

Aya Sugiyama et al.

Summary: This cross-sectional study investigated the post-acute consequences of COVID-19 and found that approximately half of the recovered patients experienced persistent symptoms. Olfactory and taste disorders, as well as cough, were the most common symptoms. Age, sex, and presence of sequelae were identified as independent risk factors for psychological distress.

SCIENTIFIC REPORTS (2022)

Review Public, Environmental & Occupational Health

Symptoms and signs of long COVID: A rapid review and meta-analysis

Quin Healey et al.

Summary: This study summarized the most common symptoms and signs associated with Long COVID through longitudinal cohort studies, including fatigue, dyspnea, olfactory dysfunction, etc. The meta-analysis showed high heterogeneity, indicating the need for cautious interpretation.

JOURNAL OF GLOBAL HEALTH (2022)

Review Environmental Sciences

Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis

Min Du et al.

Summary: Although many studies have been conducted on long COVID-19, the differences caused by different SARS-CoV-2 strains have not been systematically studied. This systematic review and meta-analysis evaluated the characteristics of long COVID-19 caused by different strains. The findings suggest that there is no significant difference between long COVID-19 caused by different strains, except for certain general symptoms and sleep difficulty. It is important to pay attention to long COVID-19 caused by unique strains and implement targeted intervention measures.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Medicine, Research & Experimental

Quality of life and persistence of COVID-19 symptoms 90 days after hospital discharge

Carolina Munoz-Corona et al.

Summary: This study aimed to describe the persistence of symptoms and quality of life (QoL) among COVID-19 patients 90 days after hospital discharge, as well as to determine differences in QoL domains based on the presence or absence of persistent symptoms. The findings showed that the majority of patients had persistent symptoms and lower QoL scores compared to those without symptoms.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2022)

Article Substance Abuse

Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey

Hugues Barthelemy et al.

Summary: Through a survey of COVID-19 patients, we found that symptoms such as cutaneous signs and tachycardia/hypertension may persist after infection. Smoking and female gender were associated with the prevalence and incidence of these symptoms.

TOBACCO INDUCED DISEASES (2022)

Review Medicine, General & Internal

Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review

Kin Israel Notarte et al.

Summary: This systematic review investigates the association between COVID-19 vaccination and long-COVID symptoms. The findings suggest that vaccination is associated with reduced risks of long-COVID, with preliminary evidence showing that two doses are more effective than one dose. The impact of vaccination on people with existing long-COVID symptoms is still controversial.

ECLINICALMEDICINE (2022)

Article Critical Care Medicine

Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?

Fabrice Thiolliere et al.

Summary: This study compared old patients hospitalized in ICU for respiratory distress due to COVID-19 with old patients hospitalized in ICU for a non-COVID-19-related reason in terms of autonomy and quality of life. The study found that COVID-19-related ICU stay was not associated with a lower quality of life or lower autonomy compared to non-COVID-19-related ICU stay.

CRITICAL CARE (2022)

Article Infectious Diseases

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Qiutang Xiong et al.

Summary: The study described the common clinical sequelae in COVID-19 survivors discharged from the hospital for more than 3 months, including general symptoms, respiratory symptoms, cardiovascular-related symptoms, psychosocial symptoms, and alopecia. Female patients were more likely to experience physical decline/fatigue, postactivity polypnoea, and alopecia.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Medicine, General & Internal

Assessment and characterisation of post-COVID-19 manifestations

Marwa Kamal et al.

Summary: The study found that the majority of COVID-19 survivors experience post-viral symptoms, with fatigue being the most common, and some experiencing severe complications such as stroke and myocarditis. The presence of comorbidities prior to COVID-19 infection is related to the severity of post-COVID-19 manifestations.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Letter Anesthesiology

Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients

Manuel Taboada et al.

BRITISH JOURNAL OF ANAESTHESIA (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Primary Health Care

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians

Heather Vance et al.

Summary: This article presents a post-COVID management tool for primary care providers to use as a quick reference for the evaluation and management of common post-COVID symptoms. It emphasizes the importance of rapid dissemination of data on long-term effects of COVID-19 to front-line PCPs.

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2021)

Review Multidisciplinary Sciences

Impact of Covid-19 on health-related quality of life of patients: A structured review

Ak Narayan Poudel et al.

Summary: The research found that the impact of Covid-19 on the HRQoL of Acute and Long Covid patients is substantial, especially in Acute Covid, females, older ages, patients with more severe disease, and patients from low-income countries.

PLOS ONE (2021)

Article Medicine, General & Internal

Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?

L. Boglione et al.

Summary: The study identified ICU admission, length of hospitalization, and treatment with remdesivir as independent predictors of LCS, with remdesivir treatment leading to a 35.9% reduction in LCS rate. Factors associated with the persistence of PCS at 6 months of follow-up include disease severity, need for ICU admission, and length of hospital stay.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

Vineet Chopra et al.

ANNALS OF INTERNAL MEDICINE (2021)

Article Multidisciplinary Sciences

Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City

Fernando Daniel Flores-Silva et al.

Summary: The study found that 15.2% of hospitalized COVID-19 patients developed new neurologic complications, with headache, myalgia, dysgeusia, and anosmia being the most common neurologic symptoms. Age, headache at presentation, preexisting neurologic disease, invasive mechanical ventilation, and neutrophil/lymphocyte ratio >= 9 were identified as independent predictors of new in-hospital neurologic complications.

PLOS ONE (2021)

Article Cardiac & Cardiovascular Systems

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin

Etheresia Pretorius et al.

Summary: Individuals with Long COVID/PASC may exhibit persistent symptoms due to the presence of persistent circulating plasma microclots that are resistant to fibrinolysis, including fatigue, shortness of breath, sleep issues, and anxiety or depression.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Infectious Diseases

Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

Maddalena Peghin et al.

Summary: The study found a high prevalence rate of post-COVID-19 syndrome at 40.2% six months after onset, with factors associated including the presence of IgG antibodies, female gender, an increase in symptom number at onset, and ICU admission. Prospective follow-up for COVID-19 patients is recommended to identify long-term sequelae early.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Health Care Sciences & Services

Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review

Cecilie Delphin Amdal et al.

Summary: This systematic review identified a wide range of health-related quality of life (HRQoL) issues experienced by COVID-19 patients, providing important information for clinicians to better recognize and treat the disease. The results also served as the basis for developing a COVID-19 specific patient-reported HRQoL questionnaire on an international scale.

QUALITY OF LIFE RESEARCH (2021)

Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Review Medicine, General & Internal

Long covid-mechanisms, risk factors, and management

Harry Crook et al.

Summary: The long-term effects of covid-19 can affect multiple systems in the body, leading to persistent symptoms that impact patients of varying severity. These symptoms include fatigue, dyspnea, and cognitive impairment, among others. Studies discuss risk factors for acute and long covid, as well as potential therapeutic options.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Microbiology

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Amy D. Proal et al.

Summary: The novel coronavirus SARS-CoV-2 has led to a pandemic of COVID-19, with some patients developing persistent symptoms known as Long COVID or PASC. These patients may have different underlying biological factors driving their symptoms, such as organ damage, persistent viral reservoirs, re-activation of pathogens, and immune dysregulation. Therapeutic approaches may need to be individualized to effectively manage care for specific patients with PASC.

FRONTIERS IN MICROBIOLOGY (2021)

Article Economics

EQ-5D-5L Health-State Values for the Mexican Population

Cristina Gutierrez-Delgado et al.

Summary: This study generated the first value set representing the stated preferences of the Mexican adult population for use in estimating QALYs. The resulting EQ-5D-5L value set is technically robust and will facilitate health economic analyses as well as quality-of-life studies.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2021)

Review Health Care Sciences & Services

Quality of life assessment instruments for adults: a systematic review of population-based studies

Nila Patricia Freire Pequeno et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2020)

Article Environmental Sciences

Persistence of COVID-19 Symptoms after Recovery in Mexican Population

Carlos E. Galvan-Tejada et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Multidisciplinary Sciences

Impact of Influenza on Health-Related Quality of Life among Confirmed (H1N1) 2009 Patients

Malen Hollmann et al.

PLOS ONE (2013)